Study Findings from Department of Pharmacotherapy and Pharmaceutical Care Provide New Insights into Respiratory Inhalant Products [The Amsa(R) Manosonic Nebulizer for Ent Disease Among Children In Poland].

A study conducted in Poland examined the effectiveness of the AMSA Manosonic nebulizer in treating common ear, nose, and throat diseases in children aged 2-17 years. The nebulizer uses acoustic vibration to create an aerosol for drug delivery, showing promising results in improving conditions such as chronic otitis media and Eustachian tube dysfunction. Budesonide was the most frequently used active substance in the nebulization treatments, with positive outcomes observed in tympanometry and otoscopy assessments. Patient compliance was highlighted as a crucial factor for the success of this treatment approach. [Extracted from the article]